SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001088856-16-000016
Filing Date
2016-05-04
Accepted
2016-05-04 13:51:28
Documents
44
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20160331x10q.htm 10-Q 841977
2 EX-31.1 cort-20160331xex31_1.htm EX-31.1 17912
3 EX-31.2 cort-20160331xex31_2.htm EX-31.2 18340
4 EX-32.1 cort-20160331xex32_1.htm EX-32.1 9439
5 EX-32.2 cort-20160331xex32_2.htm EX-32.2 9664
  Complete submission text file 0001088856-16-000016.txt   2559196

Data Files

Seq Description Document Type Size
6 EX-101.INS cort-20160331.xml EX-101.INS 381607
7 EX-101.SCH cort-20160331.xsd EX-101.SCH 20986
8 EX-101.CAL cort-20160331_cal.xml EX-101.CAL 36038
9 EX-101.DEF cort-20160331_def.xml EX-101.DEF 42181
10 EX-101.LAB cort-20160331_lab.xml EX-101.LAB 156639
11 EX-101.PRE cort-20160331_pre.xml EX-101.PRE 129220
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 161618597
SIC: 2834 Pharmaceutical Preparations